Publication: Utilization of whole-cell MALDI-TOF mass spectrometry to differentiate Burkholderia pseudomallei wild-type and constructed mutants
Issued Date
2015-12-01
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-84957110893
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.10, No.12 (2015)
Suggested Citation
Suthamat Niyompanich, Kitima Srisanga, Janthima Jaresitthikunchai, Sittiruk Roytrakul, Sumalee Tungpradabkul Utilization of whole-cell MALDI-TOF mass spectrometry to differentiate Burkholderia pseudomallei wild-type and constructed mutants. PLoS ONE. Vol.10, No.12 (2015). doi:10.1371/journal.pone.0144128 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35056
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Utilization of whole-cell MALDI-TOF mass spectrometry to differentiate Burkholderia pseudomallei wild-type and constructed mutants
Other Contributor(s)
Abstract
© 2015 Niyompanich et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original author and source are credited. Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has been widely adopted as a useful technology in the identification and typing of microorganisms. This study employed the whole-cell MALDI-TOF MS to identify and differentiate wild-type and mutants containing constructed single gene mutations of Burkholderia pseudomallei, a pathogenic bacterium causing melioidosis disease in both humans and animals. Candidate biomarkers for the B. pseudomallei mutants, including rpoS, ppk, and bpsI isolates, were determined. Taxon-specific and clinical isolate-specific biomarkers of B. pseudomallei were consistently found and conserved across all average mass spectra. Cluster analysis of MALDI spectra of all isolates exhibited separate distribution. A total of twelve potential mass peaks discriminating between wild-type and mutant isolates were identified using ClinProTools analysis. Two peaks (m/z 2721 and 2748 Da) were specific for the rpoS isolate, three (m/z 3150, 3378, and 7994 Da) for ppk, and seven (m/z 3420, 3520, 3587, 3688, 4623, 4708, and 5450 Da) for bpsI. Our findings demonstrated that the rapid, accurate, and reproducible mass profiling technology could have new implications in laboratory-based rapid differentiation of extensive libraries of genetically altered bacteria.